Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 KD Pharma Acquires Rohner AG Manufacturing Assets | Contract Pharma

What are you searching for?

Sign in
Breaking News

KD Pharma Acquires Rohner AG Manufacturing Assets

Acquisition expands KD Pharma’s CDMO capabilities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The KD Pharma Group has acquired the manufacturing assets of the former Rohner AG. The assets give KD Pharma access to new complementary technologies that will allow the company to further expand its pharmaceutical CDMO business. In addition, KD Pharma has strengthened its CDMO team by hiring several key personnel from the former Rohner team.
 
“KD Pharma has all the technology, capacity, and people to become an even larger player in the CDMO market,” said Oscar Groet, CEO of the KD Pharma Group. “Rohner was known for its unique chemical processes and technological capabilities, enabling it to manufacture difficult, multi-step pharmaceutical intermediates and APIs. This is a natural fit with our strategy to create health solutions and provide value to customers by utilizing a unique toolbox of technologies.”
 
The KD Pharma Group has an existing CDMO site in the UK, as well as a contract softgel manufacturing site in the U.S. and omega-3 manufacturing sites in Norway and Germany.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters